(Q35769121)

English

Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial

scientific article published on 7 April 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

Daclizumab, a humanised monoclonal antibody to the interleukin 2 receptor (CD25), for the treatment of moderately to severely active ulcerative colitis: a randomised, double blind, placebo controlled, dose ranging trial (English)

1 reference

Europe PubMed Central

10 August 2017

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

monoclonal antibody

1 reference

based on heuristic

inferred from title

William Jeffery Sandborn

2

object named as

W J Sandborn

1 reference

Europe PubMed Central

10 August 2017

Brian G. Feagan

3

object named as

B G Feagan

1 reference

Europe PubMed Central

10 August 2017

Stephan R. Targan

13

object named as

S R Targan

1 reference

Europe PubMed Central

10 August 2017

14

object named as

P Rutgeerts

1 reference

Europe PubMed Central

10 August 2017

author name string

G Van Assche

1

1 reference

Europe PubMed Central

10 August 2017

B A Salzberg

4

1 reference

Europe PubMed Central

10 August 2017

D Silvers

5

1 reference

Europe PubMed Central

10 August 2017

P S Monroe

6

1 reference

Europe PubMed Central

10 August 2017

W M Pandak

7

1 reference

Europe PubMed Central

10 August 2017

F H Anderson

8

1 reference

Europe PubMed Central

10 August 2017

J F Valentine

9

1 reference

Europe PubMed Central

10 August 2017

G E Wild

10

1 reference

Europe PubMed Central

10 August 2017

D J Geenen

11

1 reference

Europe PubMed Central

10 August 2017

R Sprague

12

1 reference

Europe PubMed Central

10 August 2017

V Vexler

15

1 reference

Europe PubMed Central

10 August 2017

D Young

16

1 reference

Europe PubMed Central

10 August 2017

R S Shames

17

1 reference

Europe PubMed Central

10 August 2017

language of work or name

0 references

publication date

7 April 2006

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

55

1 reference

Europe PubMed Central

10 August 2017

1568-1574

1 reference

Europe PubMed Central

10 August 2017

11

1 reference

Europe PubMed Central

10 August 2017

A reproducible grading scale for histological assessment of inflammation in ulcerative colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860086

12 July 2018

Inflammatory bowel disease: etiology and pathogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860086

12 July 2018

Cyclosporine in severe ulcerative colitis refractory to steroid therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860086

12 July 2018

Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860086

12 July 2018

Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860086

25 September 2018

Intravenous cyclosporine versus intravenous corticosteroids as single therapy for severe attacks of ulcerative colitis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1860086

25 September 2018

Anti-interleukin-2 receptor monoclonal antibodies in renal transplantation

1 reference

https://pubmed.ncbi.nlm.nih.gov/16603634

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody

1 reference

https://pubmed.ncbi.nlm.nih.gov/16603634

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intestinal inflammation observed in IL-2R/IL-2 mutant mice is associated with impaired intestinal T lymphopoiesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16603634

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Successful in vivo blockade of CD25 (high-affinity interleukin 2 receptor) on T cells by administration of humanized anti-Tac antibody to patients with psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16603634

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A pilot study on the use of the humanized anti-interleukin-2 receptor antibody daclizumab in active ulcerative colitis

1 reference

https://pubmed.ncbi.nlm.nih.gov/16603634

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study

1 reference

https://pubmed.ncbi.nlm.nih.gov/16603634

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. Daclizumab Triple Therapy Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/16603634

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/GUT.2005.089854

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35769121&oldid=1647902105"